Charles Schwab’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.3M Buy
727,420
+15,523
+2% +$411K ﹤0.01% 1697
2025
Q1
$17.2M Sell
711,897
-16,755
-2% -$405K ﹤0.01% 1711
2024
Q4
$29.3M Buy
728,652
+13,055
+2% +$525K 0.01% 1468
2024
Q3
$45.3M Buy
715,597
+44,122
+7% +$2.79M 0.01% 1189
2024
Q2
$35.6M Sell
671,475
-167,509
-20% -$8.88M 0.01% 1297
2024
Q1
$68.8M Buy
838,984
+63,285
+8% +$5.19M 0.02% 809
2023
Q4
$14.4M Buy
775,699
+10,379
+1% +$193K ﹤0.01% 1793
2023
Q3
$8.47M Buy
765,320
+505,578
+195% +$5.6M ﹤0.01% 1995
2023
Q2
$4.21M Buy
259,742
+223,074
+608% +$3.62M ﹤0.01% 2300
2023
Q1
$611K Buy
36,668
+7,702
+27% +$128K ﹤0.01% 2885
2022
Q4
$272K Hold
28,966
﹤0.01% 3136
2022
Q3
$79K Sell
28,966
-15,500
-35% -$42.3K ﹤0.01% 3241
2022
Q2
$129K Sell
44,466
-151,944
-77% -$441K ﹤0.01% 3269
2022
Q1
$590K Buy
196,410
+19,084
+11% +$57.3K ﹤0.01% 3053
2021
Q4
$816K Buy
177,326
+5,231
+3% +$24.1K ﹤0.01% 2982
2021
Q3
$1.08M Buy
172,095
+556
+0.3% +$3.49K ﹤0.01% 2847
2021
Q2
$1.03M Buy
171,539
+5,084
+3% +$30.5K ﹤0.01% 2921
2021
Q1
$1.05M Buy
166,455
+11,372
+7% +$71.9K ﹤0.01% 2837
2020
Q4
$874K Sell
155,083
-264
-0.2% -$1.49K ﹤0.01% 2815
2020
Q3
$905K Sell
155,347
-6,131
-4% -$35.7K ﹤0.01% 2700
2020
Q2
$1.17M Sell
161,478
-6,675
-4% -$48.2K ﹤0.01% 2579
2020
Q1
$787K Buy
168,153
+3,203
+2% +$15K ﹤0.01% 2547
2019
Q4
$1.32M Buy
164,950
+2,582
+2% +$20.7K ﹤0.01% 2523
2019
Q3
$1.12M Buy
162,368
+14,021
+9% +$96.5K ﹤0.01% 2536
2019
Q2
$1.23M Buy
148,347
+13,692
+10% +$114K ﹤0.01% 2506
2019
Q1
$1.34M Buy
134,655
+5,473
+4% +$54.4K ﹤0.01% 2468
2018
Q4
$989K Buy
129,182
+17,800
+16% +$136K ﹤0.01% 2542
2018
Q3
$1.94M Buy
111,382
+19,282
+21% +$336K ﹤0.01% 2432
2018
Q2
$875K Buy
+92,100
New +$875K ﹤0.01% 2617